T2* magnetic resonance and myocardial iron in thalassemia.
about
Introduction to Cardiovascular Magnetic Resonance: Technical Principles and Clinical ApplicationsEfficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromesGuidelines on haemovigilance of post-transfusional iron overloadThe Diagnostic Value of Pulsed Wave Tissue Doppler Imaging in Asymptomatic Beta- Thalassemia Major Children and Young Adults; Relation to Chemical Biomarkers of Left Ventricular Function and Iron Overload.ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases.Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions.R2* imaging of transfusional iron burden at 3T and comparison with 1.5T.Mapping iron in human heart tissue with synchrotron x-ray fluorescence microscopy and cardiovascular magnetic resonance.Optimal method for early detection of cardiac disorders in thalassemia major patients: magnetic resonance imaging or echocardiography?Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart.Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadT2* magnetic resonance imaging of the liver in thalassemic patients in Iran.Magnetic resonance comparison of left-right heart volumetric and functional parameters in thalassemia major and thalassemia intermedia patients.Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndromeElectrocardiographic consequences of cardiac iron overload in thalassemia major.Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort.New developments and controversies in iron metabolism and iron chelation therapy.The Association between Serum Ferritin Level, Tissue Doppler Echocardiography, Cardiac T2* MRI, and Heart Rate Recovery in Patients with Beta Thalassemia Major.MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.Evaluation of tissue doppler echocardiography and T2* magnetic resonance imaging in iron load of patients with thalassemia major.Application of cardiac magnetic resonance imaging in cardiomyopathyModified Look-Locker T1 evaluation using Bloch simulations: human and phantom validation.Imaging sequences in cardiovascular magnetic resonance: current role, evolving applications, and technical challenges.Magnetic resonance imaging in the evaluation of congestive cardiac failure.Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload.Cardiac complications in thalassemia major.Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.Value of severe liver iron overload for assessing heart iron levels in thalassemia major patients.Evaluation of myocardial and hepatic iron loading by MRI T2* in multi-transfused patients with repeated blood loss as compared to thalassaemia major patients and controlsA practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.Assessment of cardiac parameters in evaluation of cardiac functions in patients with thalassemia major.Assessment of iron overload in very young children with limited thalassemia care resources in South China.The effect of HFE polymorphisms on cardiac iron overload in patients with beta-thalassemia major.Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.Fetal liver T2* values: defining a standardized scale.Influence of the analysis technique on estimating hepatic iron content using MRI.Assessment of left ventricular functions and myocardial iron load with tissue Doppler and speckle tracking echocardiography and T2* MRI in patients with β-thalassemia major.Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.
P2860
Q26749269-941B1DB9-032B-4FB2-8906-A645E0F43354Q26764818-A667F616-E3AF-430D-B75C-88ABA92351FBQ27022721-91F73697-A931-48A6-B991-162C26FD639DQ30402562-DC9E7666-53B3-4BBA-AFC4-06E0C4E1DC2AQ30475186-5CB9D56D-FC62-4EC7-B75D-EB8E4E2FA0A2Q30853786-808C6CA0-A34B-489F-973A-725A0E5D9B73Q31037298-706A4A21-4640-48F6-AF5B-9BF9C797672AQ33907529-14521422-C9E1-4EB9-B753-1799B0A3DD1BQ34255213-EBC5C3B3-80B5-46D1-8F69-E58BC009AE0FQ34302477-7A1A2678-3B72-451C-9BC2-0EC4A4F2E46DQ34422736-34B2515A-AB24-4013-B20E-EABFE855773EQ34451527-FB21AE1A-B0FC-4E94-BE2E-FCD84B765DDEQ34521453-9286EA1B-0A14-4C42-A3F4-D618583280D1Q35438051-7957487E-6E77-4E0B-89FB-02EEB09FFC81Q35743810-6B493DE8-6EFB-4DA7-BFB4-4E284668DFA0Q35836446-FEF94278-ADCE-4FD3-A159-24A66B398D99Q35891598-AAB2F7A5-8AAB-4C95-B7DD-17414024DEDAQ36719376-790288FF-14D7-4518-B4BA-3C259E1BBB85Q36754372-74B332B3-2848-4831-B39C-92DE2E40F1E6Q36915101-0AE3E3B0-A16C-4ED2-8090-F4BFE7968F7DQ37128475-D3DC1C49-0707-487A-B954-28CD8F5B43D7Q37254551-090025E6-1346-4C5A-99F0-C1B8938AF9ADQ37305681-66D2C13E-BB3F-46E5-A691-54144E371D0BQ37996910-94C823A2-1452-4F01-9DE2-6A75B30F9A5EQ38100155-FE6A151B-DE1F-41DE-973A-3621331CF039Q38134738-1928455A-DFAB-4974-BCD4-224F1AA62AECQ38608472-F14EDC91-F620-4F9B-BE84-CB9B91139BFAQ38768594-FCF37651-C2AA-40D3-B643-BFC9CBBCA903Q38984255-273B9E36-066F-41E5-8474-FB1B753E6CF1Q39869729-A41500EA-7A81-4E3A-8BAD-F58D88CBE3F4Q42809780-5AC0F572-9FB7-4989-897A-D1AEA832016BQ43265087-A6A94357-0C96-428E-8DC8-05355912F389Q44388142-1132FA43-5E7D-44CE-B35E-1F4E43E713A1Q45056349-E5C1F51B-6D8C-4702-A35E-4A4223B71A5DQ45087450-333DE49A-3E39-487D-842A-1440745D2EB9Q45421534-A61D66DC-4F01-48A9-9DF9-77978C9353F4Q46590748-D29FA66A-35D1-4EB8-8FDD-7B8854FC6B65Q46728010-732F29BE-A0B0-43C4-AAE8-4E941E2E856EQ48295158-38BBFACE-1DF2-4C67-A75C-B1C4C75C56F5Q48557800-6FE83BDE-32D0-4EB3-9064-4897170D54E2
P2860
T2* magnetic resonance and myocardial iron in thalassemia.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
T2* magnetic resonance and myocardial iron in thalassemia.
@ast
T2* magnetic resonance and myocardial iron in thalassemia.
@en
type
label
T2* magnetic resonance and myocardial iron in thalassemia.
@ast
T2* magnetic resonance and myocardial iron in thalassemia.
@en
prefLabel
T2* magnetic resonance and myocardial iron in thalassemia.
@ast
T2* magnetic resonance and myocardial iron in thalassemia.
@en
P356
P1476
T2* magnetic resonance and myocardial iron in thalassemia.
@en
P304
P356
10.1196/ANNALS.1345.045
P407
P577
2005-01-01T00:00:00Z